Salesforce is trading lower as investors exercise caution ahead of the company's upcoming earnings report on August 26. The stock is currently facing technical headwinds, having recently tested a key resistance zone near the 210 dollar level. This downward movement also follows news that Veeva Systems secured major CRM contracts with Biogen and Regeneron, potentially signaling increased competitive pressure in the software application space.